GL1X · GenesisL1 explorer

MolNFT v1 · #171674 · protein

Syk kinase domain in complex with azabenzimidazole inhibitor 3

6ZCS · Tyrosine-protein kinase syk: “Syk kinase domain in complex with azabenzimidazole inhibitor 3”. X-ray diffraction, 1 ligand (QFE), 1 pocket (best druggability 0.62). MolNFT v1 #171674 on GenesisL1: 3D structure, binding sites and…

PDB
6ZCS
Type
protein
Length
269 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Tyrosine-protein kinase syk
EC
2.7.10.2
UniProt
P43405
Ligands
QFE
Pockets
1 · best druggability 0.62

Structure

x-ray diffraction · 1 distinct chain · 41% helix, 23% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ATyrosine-protein kinase syk (EC 2.7.10.2)protein26941% helix, 23% strandP43405

Ligands and binding sites

  • QFE · (3~{R},4~{R})-~{N}4-[1-[2-(1-methylindol-4-yl)-3~{H}-imidazo[4,5-b]pyridin-7-yl]pyrazol-4-yl]oxane-3,4-diamine · ligand · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

1 pocket found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
12780.620.8032QFE

Compared structures

  • 6ZCS · SYK Kinase domain in complex with azabenzimidazole inhibitor 3 · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.